GAO: FDA yet to make safety changes post-Vioxx

Courtesy Headlines from the Associated Press  Tue, 12/08/2009 - 23:01

WASHINGTON (AP) -- The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal....

Tags:

 

More related items

GAO: FDA fails to follow up on unproven drugs
WASHINGTON (AP) -- The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients'...

FDA approves new skin cancer drug first tested in...
(The Translational Genomics Research Institute) A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare...

Can You Sue the Government? FDA Whistleblowers Sue...
From the Washington Post:FDA staffers sue agency over surveillance of personal e-mailEllen Nakashima and Lisa ReinJanuary 29, 2012The Food and Drug Administration secretly monitored the...

Schiff Melatonin Plus 3 mg Melatonin with 25 mg...
Melatonin is a metabolic hormone made in the pineal gland, retina, and intestines. Melatonin is released into the blood stream by the pineal gland (which resides in the brain) to set your...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com